section name header

Pronunciation

kee-toe-KOE-na-zole

Classifications

Therapeutic Classification: antifungals

Pharmacologic Classification: imidazoles

Indications

REMS


Action

  • Affects the synthesis of the fungal cell wall.
Therapeutic effects:
  • Decreased symptoms of fungal infection.

Pharmacokinetics

Absorption: Minimal absorption through intact skin.

Distribution: If absorption occurs, widely distributed; crosses the placenta; enters breast milk. Action after topical administration is primarily local.

Metabolism/Excretion: If absorbed, partially metabolized by the liver then excreted in feces via biliary excretion.

Half-Life: If absorbed, 8 hr.

Time/Action Profile

(resolution of symptoms/lesions)

ROUTEONSETPEAKDURATION
Topicalunknownunknownunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: hair loss (shampoo)

Local: burning, itching, local hypersensitivity reactions, redness, stinging

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Ketodan, Nizoral, Nizoral A-D, Xolegel

Canadian Brand Names

Ketoderm